Who Paid My Doc
John Wood
Pediatric Cardiology Los Angeles, CA Medical Doctor
NPI 1982707097 CMS profile 271487
4650 W Sunset Blvd, Los Angeles, CA 90027
General payments
$122,398
Research payments
$3,590
Ownership & investment interest
$0
Research they led as principal investigator
$77,162
Through program year 2025, John Wood of Los Angeles, CA is reported in the CMS Open Payments database as having received $122,398 across 64 general payments and $3,590 in research payments paid to them. Separately, studies naming them as principal investigator received $77,162 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 98th percentile of Pediatric Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
9 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $24,196 | 15 | |
| 2025 | Research | $390 | 1 | |
| 2024 | General | $36,002 | 10 | |
| 2023 | General | $19,667 | 8 | |
| 2022 | General | $14,672 | 9 | |
| 2021 | General | $10,018 | 3 | |
| 2020 | General | $3,290 | 13 | |
| 2019 | General | $14,553 | 6 | |
| 2019 | Research | $3,200 | 1 |
Beside peers
- John Wood
- Pediatric Cardiology median
- Middle half of Pediatric Cardiology
- National median
In program year 2025, general payments to John Wood were reported at $24,196. Among 1,168 Pediatric Cardiology profiles paid that year, the median was $146 and the middle half received between $47 and $670.
Show as a table
| Year | John Wood | Pediatric Cardiology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $14,553 | $124 | $35–$516 | $163 |
| 2020 | $3,290 | $70 | $23–$326 | $114 |
| 2021 | $10,018 | $112 | $27–$445 | $132 |
| 2022 | $14,672 | $129 | $36–$680 | $149 |
| 2023 | $19,667 | $149 | $38–$826 | $160 |
| 2024 | $36,002 | $131 | $37–$652 | $164 |
| 2025 | $24,196 | $146 | $47–$670 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
66 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Cardiology in California
Doff McElhinney
Pediatric Cardiology · Palo Alto, CA
Daniel Levi
Pediatric Cardiology · Los Angeles, CA
Brent Gordon
Pediatric Cardiology · San Diego, CA
Frank Ing
Pediatric Cardiology · Sacramento, CA
Henri Justino
Pediatric Cardiology · San Diego, CA
Leigh Reardon
Pediatric Cardiology · Los Angeles, CA
Related records
Pediatric Cardiology in California
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Cardiology
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.